These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35656181)

  • 21. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
    Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
    Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermoresponsive physical hydrogels of poly(lactic acid)/poly(ethylene glycol) stereoblock copolymers tuned by stereostructure and hydrophobic block sequence.
    Mao H; Shan G; Bao Y; Wu ZL; Pan P
    Soft Matter; 2016 May; 12(20):4628-37. PubMed ID: 27121732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation.
    Chen S; Singh J
    Int J Pharm; 2005 May; 295(1-2):183-90. PubMed ID: 15848003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
    Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Situ Forming Injectable Thermoresponsive Hydrogels for Controlled Delivery of Biomacromolecules.
    Dutta K; Das R; Ling J; Monibas RM; Carballo-Jane E; Kekec A; Feng DD; Lin S; Mu J; Saklatvala R; Thayumanavan S; Liang Y
    ACS Omega; 2020 Jul; 5(28):17531-17542. PubMed ID: 32715238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE).
    Wei PS; Chen YJ; Lin SY; Chuang KH; Sheu MT; Ho HO
    Biomaterials; 2021 Nov; 278():121166. PubMed ID: 34634663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracranial In Situ Thermosensitive Hydrogel Delivery of Temozolomide Accomplished by PLGA-PEG-PLGA Triblock Copolymer Blending for GBM Treatment.
    Gu W; Fan R; Quan J; Cheng Y; Wang S; Zhang H; Zheng A; Song S
    Polymers (Basel); 2022 Aug; 14(16):. PubMed ID: 36015626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel thermosensitive pentablock copolymers for sustained delivery of proteins in the treatment of posterior segment diseases.
    Patel SP; Vaishya R; Yang X; Pal D; Mitra AK
    Protein Pept Lett; 2014; 21(11):1185-200. PubMed ID: 25315374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLGA-PEG-PLGA tri-block copolymers as in situ gel-forming peptide delivery system: effect of formulation properties on peptide release.
    Ghahremankhani AA; Dorkoosh F; Dinarvand R
    Pharm Dev Technol; 2008; 13(1):49-55. PubMed ID: 18300099
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Ng F; Nicoulin V; Peloso C; Curia S; Richard J; Lopez-Noriega A
    ACS Appl Mater Interfaces; 2023 Dec; 15(48):55495-55509. PubMed ID: 38011651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injectable supramolecular hydrogel from insulin-loaded triblock PCL-PEG-PCL copolymer and γ-cyclodextrin with sustained-release property.
    Khodaverdi E; Heidari Z; Tabassi SA; Tafaghodi M; Alibolandi M; Tekie FS; Khameneh B; Hadizadeh F
    AAPS PharmSciTech; 2015 Feb; 16(1):140-9. PubMed ID: 25224297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel.
    Gong C; Shi S; Dong P; Kan B; Gou M; Wang X; Li X; Luo F; Zhao X; Wei Y; Qian Z
    Int J Pharm; 2009 Jan; 365(1-2):89-99. PubMed ID: 18793709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of PLGA-PEG-PLGA copolymer hydrogel for sustained drug delivery in the ear.
    Feng L; Ward JA; Li SK; Tolia G; Hao J; Choo DI
    Curr Drug Deliv; 2014; 11(2):279-86. PubMed ID: 24438444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ gelling polyvalerolactone-based thermosensitive hydrogel for sustained drug delivery.
    Mishra GP; Kinser R; Wierzbicki IH; Alany RG; Alani AW
    Eur J Pharm Biopharm; 2014 Oct; 88(2):397-405. PubMed ID: 24931340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro, ex-vivo, and in-vivo evaluation of buprenorphine HCl release from an in situ forming gel of PLGA-PEG-PLGA using N‑methyl‑2‑pyrrolidone as solvent.
    Kamali H; Khodaverdi E; Hadizadeh F; Mohajeri SA
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():561-575. PubMed ID: 30606566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.
    He G; Ma LL; Pan J; Venkatraman S
    Int J Pharm; 2007 Apr; 334(1-2):48-55. PubMed ID: 17116377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.
    Zhang Y; Wu X; Han Y; Mo F; Duan Y; Li S
    Int J Pharm; 2010 Feb; 386(1-2):15-22. PubMed ID: 19895878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-conjugated PLA-PEG-PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formation.
    Danafar H; Rostamizadeh K; Davaran S; Hamidi M
    Pharm Dev Technol; 2017 Dec; 22(8):947-957. PubMed ID: 26740008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits.
    Rezaeian Shiadeh SN; Hadizadeh F; Khodaverdi E; Gorji Valokola M; Rakhshani S; Kamali H; Nokhodchi A
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.